66537

You are here

Does Genotype Define Disease: The Case of Pediatric Sarcomas

A subscription to the 2012 ASCO Annual Meeting is required to view presentations in this session Subscription Information

Education Session

Chair(s):

Stephen L. Lessnick, MD, PhD;

Cancer Genetics Track 2012 ASCO Annual Meeting

Molecular and Genomic Diagnostics in Pediatric Oncology: When and How They Should Be Implemented

Stephen L. Lessnick, MD, PhD
Chair

» Listen (Right-click to download audio)

A subscription to the 2012 ASCO Annual Meeting is required to view presentations in this session Subscription Information

More by Stephen L. Lessnick :

Abstracts

Capecitabine (Cape) versus 5-fluorouracil (5-FU)–based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial.

Meeting: 2011 ASCO Annual Meeting
Abstract No: 3504
First Author: R. Hofheinz
Category: Gastrointestinal (Colorectal) Cancer - Colorectal Cancer
Defining two prognostic groups of metastatic gastric cancer: FLOT3 trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Meeting: 2011 ASCO Annual Meeting
Abstract No: 4070
First Author: S. Al-Batran
Category: Gastrointestinal (Noncolorectal) Cancer - Esophageal, Gastric, or Small Bowel
Identification of potential molecular candidate lesions by molecular analysis of desmoid tumors with qrt-PCR and high-density SNP arrays.

Meeting: 2011 ASCO Annual Meeting
Abstract No: 10081
First Author: P. Erben
Category: Sarcoma - Soft Tissue

Virtual Meeting Presentations

Capecitabine (cape)-associated hand-foot skin reaction (HFS) as a clinical predictor of improved survival in patients (pts) with colorectal cancer.

Meeting: 2012 ASCO Annual Meeting
Session: Gastrointestinal (Colorectal) Cancer(General Poster Session)
Presenter: Ralf Hofheinz
Bevacizumab in the first-line treatment of elderly patients with metastatic colorectal cancer: Mature results from a large community-based observational study.

Meeting: 2012 Gastrointestinal Cancers Symposium
Session: General Poster Session C: Cancers of the Colon and Rectum(General Poster Session)
Presenter: Ralf Hofheinz
Panitumumab (pmab) with FOLFIRI as first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC): Resections and curative surgery in a phase II single arm, multicenter study (20060314).

Meeting: 2010 ASCO Annual Meeting
Session: Gastrointestinal (Colorectal) Cancer(General Poster Session)
Presenter: Ralf Hofheinz

Educational Book Manuscripts